Xiaowei Dong
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 3
- Cancer Treatment and Pharmacology 2
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 11
- Co-authors
- Russell J. Mumper (4 shared papers)Val R. Adams (2 shared papers)Cynthia A. Mattingly (2 shared papers)Michael T. Tseng (2 shared papers)Moo J. Cho (1 shared paper)Yang Liu (1 shared paper)Ping Ma (1 shared paper)Anshul Gupte (1 shared paper)
- Journals
- PLoS ONE (3 papers)Pharmaceutics (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Journal of Biomedical Nanotechnology (2 papers)International Journal of Pharmaceutics (2 papers)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Xiaowei Dong
38 papers receiving 1.9k citations
Xiaowei Dong's Hit Papers
Peers
Comparison fields: 5 of 125
- Biomaterials 627
- Pharmaceutical Science 262
- Neurology 147
- Oncology 303
- Molecular Biology 711
Countries citing papers authored by Xiaowei Dong
This map shows the geographic impact of Xiaowei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Dong more than expected).
Fields of papers citing papers by Xiaowei Dong
This network shows the impact of papers produced by Xiaowei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Dong. The network helps show where Xiaowei Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowei Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Current Strategies for Brain Drug Delivery Hit paper breakdown → | 2018 | 730 |
| 2 | 2010 | 256 | |
| 3 | 2009 | 251 | |
| 4 | 2009 | 137 | |
| 5 | 2019 | 91 | |
| 6 | 2008 | 73 | |
| 7 | 2020 | 50 | |
| 8 | 2000 | 49 | |
| 9 | 2020 | 38 | |
| 10 | 2016 | 38 | |
| 11 | 2021 | 33 | |
| 12 | 2022 | 31 | |
| 13 | 2019 | 24 | |
| 14 | 2016 | 17 | |
| 15 | 2010 | 16 | |
| 16 | 2021 | 11 | |
| 17 | 2016 | 11 | |
| 18 | 2022 | 9 | |
| 19 | 2021 | 7 | |
| 20 | 2021 | 7 |
About Xiaowei Dong
Xiaowei Dong is a scholar working on Oncology, Biomaterials, Pharmaceutical Science, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Drug Solubulity and Delivery Systems (7 papers), Analytical Chemistry and Chromatography (4 papers), Advanced Drug Delivery Systems (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Barrier Structure and Function Studies (2 papers), Prostate Cancer Treatment and Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Biomaterials (627 citations), Pharmaceutical Science (262 citations), Neurology (147 citations), Oncology (303 citations) and Molecular Biology (711 citations). Xiaowei Dong has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Russell J. Mumper, Val R. Adams, Cynthia A. Mattingly, Michael T. Tseng, Moo J. Cho, Yang Liu, Ping Ma, Anshul Gupte, Markos Leggas and Harry C. Ledebur. Their work appears in journals such as PLoS ONE, Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Biomedical Nanotechnology and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.